<p>Naviter Wealth LLC 在最近向证券交易委员会的披露中表示，在第四季度将其在美敦力公司（NYSE:MDT - 免费报告）的持股比例提高了 19.1%。该基金在季度内购买了 3,120 股后，持有该医疗技术公司 19,473 股股票。根据其最新的 SEC 文件，Naviter Wealth LLC 在美敦力的持股价值为 1,569,000 美元。</p>
<ul>
<li>MarketBeat 周回顾 – 02/17 - 02/21</li>
</ul>
<p>其他几家对冲基金和机构投资者最近也买卖了该股票的股份。Larson Financial Group LLC 在第四季度将其在美敦力的持仓增加了 20.1%。Larson Financial Group LLC 现在拥有 29,635 股该医疗技术公司的股票，价值 2,367,000 美元，此前在该期间又购买了 4,960 股。瑞士银行 Julius Baer &amp; Co. Ltd 在第四季度将其在美敦力的股份增加了 174.3%。瑞士银行 Julius Baer &amp; Co. Ltd 现在拥有 894,086 股该医疗技术公司的股票，价值 75,994,000 美元，此前在上个季度又收购了 568,107 股。Machina Capital S.A.S.在第四季度收购了美敦力的新股份，价值约为 1,534,000 美元。Aviance Capital Partners LLC 在第四季度将其在美敦力的股份增加了 9.9%。Aviance Capital Partners LLC 现在拥有 4,376 股该医疗技术公司的股票，价值 350,000 美元，此前在上个季度又购买了 396 股。最后，AMG National Trust Bank 在第四季度将其在美敦力的持股提高了 10.6%。AMG National Trust Bank 现在拥有 2,760 股该医疗技术公司的股票，价值 220,000 美元，此前在该期间又购买了 265 股。82.06% 的股票由机构投资者和对冲基金持有。</p>
<h2>美敦力股价上涨 1.6%</h2>
<p>美敦力股票周五开盘价为 94.58 美元。该公司的债务与股本比率为 0.48，流动比率为 1.90，速动比率为 1.39。该股票的 50 日简单移动平均线为 88.33 美元，200 日简单移动平均线为 87.80 美元。该股票的市值为 1213 亿美元，市盈率为 28.75，市盈增长比率为 2.22，贝塔值为 0.80。美敦力公司的 1 年最低价为 75.96 美元，1 年最高价为 95.57 美元。</p>
<ul>
<li>美敦力的扩张势头增强——市场转变的时机到了吗？</li>
</ul>
<p>美敦力（NYSE:MDT - 获取免费报告）最近于 2 月 18 日星期二发布了季度财报。该医疗技术公司报告的每股收益为 1.39 美元，超出分析师一致预期的 1.36 美元，超出幅度为 0.03 美元。该公司本季度的收入为 82.9 亿美元，而分析师预期为 83.3 亿美元。美敦力的股本回报率为 14.07%，净利润率为 12.83%。分析师预测美敦力将在当前财政年度发布 5.46 的每股收益。</p>
<h2>美敦力股息公告</h2>
<p>该公司最近还宣布了一项季度股息，将于 4 月 11 日星期五支付。3 月 28 日星期五的股东将获得每股 0.70 美元的股息。这相当于年化 2.80 美元的股息，收益率为 2.96%。除息日为 3 月 28 日星期五。美敦力的股息支付比率（DPR）目前为 85.11%。</p>
<h2>分析师设定新目标价</h2>
<ul>
<li>Intuitive Surgical 在机器人手术创新中领先</li>
</ul>
<p>几家券商对 MDT 发表了评论。富国银行将美敦力的目标价从 106.00 美元下调至 98.00 美元，并在 11 月 20 日星期三的报告中对该股票给予了 “增持” 评级。加拿大皇家银行在 2 月 19 日星期三的研究报告中重新发布了 “跑赢大盘” 评级，并对美敦力的股票设定了 105.00 美元的目标价。Needham &amp; Company LLC 在 2 月 19 日星期三的研究报告中重申了对美敦力股票的 “持有” 评级。Robert W. Baird 在 2 月 19 日星期三的报告中将美敦力股票的目标价从 90.00 美元提高至 91.00 美元，并给予该公司 “中性” 评级。最后，瑞银集团在 2 月 19 日星期三的研究报告中将美敦力股票的目标价从 85.00 美元提高至 95.00 美元，并给予该股票 “中性” 评级。一位投资分析师对该股票给予了卖出评级，八位分析师给予持有评级，六位分析师给予买入评级，还有一位分析师对该公司的股票给予了强烈买入评级。根据 MarketBeat.com 的数据，该公司的共识评级为 “持有”，平均目标价为 96.07 美元。</p>
<p><strong>获取我们关于 MDT 的最新报告</strong></p>
<h2>内部人士下注</h2>
<p>在其他美敦力新闻中，执行副总裁 Brett A. Wall 于 1 月 8 日星期三出售了 9,850 股该公司的股票。该股票以 80.41 美元的平均价格出售，总交易额为 792,038.50 美元。交易完成后，该执行副总裁现在持有 40,708 股公司的股票，价值 3,273,330.28 美元。这笔交易代表其持股比例减少了 19.48%。该交易已在向证券交易委员会的法律文件中披露，相关信息可通过 SEC 网站获取。0.20% 的股票由内部人士持有。</p>
<h2>关于美敦力</h2>
<p>（免费报告）</p>
<p>美敦力公司开发、制造和销售基于设备的医疗疗法，面向全球的医疗系统、医生、临床医生和患者。其心血管产品组合提供可植入的心脏起搏器、心脏复律除颤器和心脏再同步治疗设备；心脏消融产品；可植入心脏监测系统；TYRX 产品；以及远程监控和以患者为中心的软件。</p>
<h2>推荐故事</h2>
<ul>
<li>我们更看好的五只股票，胜过美敦力</li>
<li>你应该将这些沃伦·巴菲特的股票加入你的投资组合吗？</li>
<li>这四只科技 ETF 刚刚触及 50 日低点——是时候买入了吗？</li>
<li>制造业股票投资</li>
<li>在其他人观望时，值得购买的三只股票</li>
<li>商业服务股票投资</li>
<li>MarketBeat 周报 – 03/03 - 03/07</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1EVA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1EVA"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1000 美元在美敦力吗？</h2>
<p>在考虑美敦力之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而美敦力并不在名单上。</p>
<p>虽然美敦力目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

美敦力

<p>Naviter Wealth LLC 在第四季度将其在美敦力（Medtronic plc，纽约证券交易所代码：MDT）的持股增加了 19.1%，目前持有 19,473 股，价值 157 万美元。其他机构投资者也增加了他们的持仓。美敦力的股票开盘价为 94.58 美元，市值为 1213 亿美元。该公司报告每股收益为 1.39 美元，超出预期，并宣布每股季度分红为 0.70 美元。分析师对该股票的评级意见不一，普遍评级为 “持有”，平均目标价为 96.07 美元</p>

<p>Naviter Wealth LLC lifted its stake in Medtronic plc (NYSE:MDT - Free Report) by 19.1% during the fourth quarter, according to its most recent disclosure with the Securities &amp; Exchange Commission. The fund owned 19,473 shares of the medical technology company's stock after buying an additional 3,120 shares during the quarter. Naviter Wealth LLC's holdings in Medtronic were worth $1,569,000 as of its most recent SEC filing.</p>
<div class="lb-trans"><p>Naviter Wealth LLC 在最近向证券交易委员会的披露中表示，在第四季度将其在美敦力公司（NYSE:MDT - 免费报告）的持股比例提高了 19.1%。该基金在季度内购买了 3,120 股后，持有该医疗技术公司 19,473 股股票。根据其最新的 SEC 文件，Naviter Wealth LLC 在美敦力的持股价值为 1,569,000 美元。</p>
</div><ul>
<li>MarketBeat Week in Review – 02/17 - 02/21</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 周回顾 – 02/17 - 02/21</li>
</ul>
</div><p>Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Larson Financial Group LLC grew its position in Medtronic by 20.1% during the fourth quarter. Larson Financial Group LLC now owns 29,635 shares of the medical technology company's stock valued at $2,367,000 after buying an additional 4,960 shares during the period. Bank Julius Baer &amp; Co. Ltd Zurich boosted its stake in shares of Medtronic by 174.3% during the 4th quarter. Bank Julius Baer &amp; Co. Ltd Zurich now owns 894,086 shares of the medical technology company's stock worth $75,994,000 after acquiring an additional 568,107 shares in the last quarter. Machina Capital S.A.S. acquired a new stake in shares of Medtronic during the 4th quarter valued at about $1,534,000. Aviance Capital Partners LLC increased its stake in shares of Medtronic by 9.9% in the 4th quarter. Aviance Capital Partners LLC now owns 4,376 shares of the medical technology company's stock valued at $350,000 after purchasing an additional 396 shares in the last quarter. Finally, AMG National Trust Bank raised its holdings in Medtronic by 10.6% in the 4th quarter. AMG National Trust Bank now owns 2,760 shares of the medical technology company's stock worth $220,000 after purchasing an additional 265 shares during the period. 82.06% of the stock is owned by institutional investors and hedge funds.</p>
<div class="lb-trans"><p>其他几家对冲基金和机构投资者最近也买卖了该股票的股份。Larson Financial Group LLC 在第四季度将其在美敦力的持仓增加了 20.1%。Larson Financial Group LLC 现在拥有 29,635 股该医疗技术公司的股票，价值 2,367,000 美元，此前在该期间又购买了 4,960 股。瑞士银行 Julius Baer &amp; Co. Ltd 在第四季度将其在美敦力的股份增加了 174.3%。瑞士银行 Julius Baer &amp; Co. Ltd 现在拥有 894,086 股该医疗技术公司的股票，价值 75,994,000 美元，此前在上个季度又收购了 568,107 股。Machina Capital S.A.S.在第四季度收购了美敦力的新股份，价值约为 1,534,000 美元。Aviance Capital Partners LLC 在第四季度将其在美敦力的股份增加了 9.9%。Aviance Capital Partners LLC 现在拥有 4,376 股该医疗技术公司的股票，价值 350,000 美元，此前在上个季度又购买了 396 股。最后，AMG National Trust Bank 在第四季度将其在美敦力的持股提高了 10.6%。AMG National Trust Bank 现在拥有 2,760 股该医疗技术公司的股票，价值 220,000 美元，此前在该期间又购买了 265 股。82.06% 的股票由机构投资者和对冲基金持有。</p>
</div><h2>Medtronic Trading Up 1.6 %</h2>
<div class="lb-trans"><h2>美敦力股价上涨 1.6%</h2>
</div><p>Shares of Medtronic stock opened at $94.58 on Friday. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.90 and a quick ratio of 1.39. The stock's 50 day simple moving average is $88.33 and its 200-day simple moving average is $87.80. The stock has a market cap of $121.30 billion, a P/E ratio of 28.75, a P/E/G ratio of 2.22 and a beta of 0.80. Medtronic plc has a 1-year low of $75.96 and a 1-year high of $95.57.</p>
<div class="lb-trans"><p>美敦力股票周五开盘价为 94.58 美元。该公司的债务与股本比率为 0.48，流动比率为 1.90，速动比率为 1.39。该股票的 50 日简单移动平均线为 88.33 美元，200 日简单移动平均线为 87.80 美元。该股票的市值为 1213 亿美元，市盈率为 28.75，市盈增长比率为 2.22，贝塔值为 0.80。美敦力公司的 1 年最低价为 75.96 美元，1 年最高价为 95.57 美元。</p>
</div><ul>
<li>Medtronic’s Expansion Gains Momentum—Time for a Market Shift?</li>
</ul>
<div class="lb-trans"><ul>
<li>美敦力的扩张势头增强——市场转变的时机到了吗？</li>
</ul>
</div><p>Medtronic (NYSE:MDT - Get Free Report) last released its quarterly earnings data on Tuesday, February 18th. The medical technology company reported $1.39 earnings per share for the quarter, topping analysts' consensus estimates of $1.36 by $0.03. The company had revenue of $8.29 billion for the quarter, compared to analyst estimates of $8.33 billion. Medtronic had a return on equity of 14.07% and a net margin of 12.83%. Analysts predict that Medtronic plc will post 5.46 EPS for the current fiscal year.</p>
<div class="lb-trans"><p>美敦力（NYSE:MDT - 获取免费报告）最近于 2 月 18 日星期二发布了季度财报。该医疗技术公司报告的每股收益为 1.39 美元，超出分析师一致预期的 1.36 美元，超出幅度为 0.03 美元。该公司本季度的收入为 82.9 亿美元，而分析师预期为 83.3 亿美元。美敦力的股本回报率为 14.07%，净利润率为 12.83%。分析师预测美敦力将在当前财政年度发布 5.46 的每股收益。</p>
</div><h2>Medtronic Dividend Announcement</h2>
<div class="lb-trans"><h2>美敦力股息公告</h2>
</div><p>The company also recently announced a quarterly dividend, which will be paid on Friday, April 11th. Shareholders of record on Friday, March 28th will be paid a dividend of $0.70 per share. This represents a $2.80 dividend on an annualized basis and a yield of 2.96%. The ex-dividend date is Friday, March 28th. Medtronic's dividend payout ratio (DPR) is presently 85.11%.</p>
<div class="lb-trans"><p>该公司最近还宣布了一项季度股息，将于 4 月 11 日星期五支付。3 月 28 日星期五的股东将获得每股 0.70 美元的股息。这相当于年化 2.80 美元的股息，收益率为 2.96%。除息日为 3 月 28 日星期五。美敦力的股息支付比率（DPR）目前为 85.11%。</p>
</div><h2>Analysts Set New Price Targets</h2>
<div class="lb-trans"><h2>分析师设定新目标价</h2>
</div><ul>
<li>Intuitive Surgical Leads the Pack in Robotic Surgery Innovation</li>
</ul>
<div class="lb-trans"><ul>
<li>Intuitive Surgical 在机器人手术创新中领先</li>
</ul>
</div><p>Several brokerages have commented on MDT. Wells Fargo &amp; Company dropped their price objective on Medtronic from $106.00 to $98.00 and set an &#34;overweight&#34; rating on the stock in a report on Wednesday, November 20th. Royal Bank of Canada reissued an &#34;outperform&#34; rating and issued a $105.00 price target on shares of Medtronic in a research note on Wednesday, February 19th. Needham &amp; Company LLC restated a &#34;hold&#34; rating on shares of Medtronic in a research report on Wednesday, February 19th. Robert W. Baird increased their price objective on shares of Medtronic from $90.00 to $91.00 and gave the company a &#34;neutral&#34; rating in a report on Wednesday, February 19th. Finally, UBS Group boosted their target price on shares of Medtronic from $85.00 to $95.00 and gave the stock a &#34;neutral&#34; rating in a research note on Wednesday, February 19th. One investment analyst has rated the stock with a sell rating, eight have issued a hold rating, six have given a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat.com, the company currently has a consensus rating of &#34;Hold&#34; and an average target price of $96.07.</p>
<div class="lb-trans"><p>几家券商对 MDT 发表了评论。富国银行将美敦力的目标价从 106.00 美元下调至 98.00 美元，并在 11 月 20 日星期三的报告中对该股票给予了 “增持” 评级。加拿大皇家银行在 2 月 19 日星期三的研究报告中重新发布了 “跑赢大盘” 评级，并对美敦力的股票设定了 105.00 美元的目标价。Needham &amp; Company LLC 在 2 月 19 日星期三的研究报告中重申了对美敦力股票的 “持有” 评级。Robert W. Baird 在 2 月 19 日星期三的报告中将美敦力股票的目标价从 90.00 美元提高至 91.00 美元，并给予该公司 “中性” 评级。最后，瑞银集团在 2 月 19 日星期三的研究报告中将美敦力股票的目标价从 85.00 美元提高至 95.00 美元，并给予该股票 “中性” 评级。一位投资分析师对该股票给予了卖出评级，八位分析师给予持有评级，六位分析师给予买入评级，还有一位分析师对该公司的股票给予了强烈买入评级。根据 MarketBeat.com 的数据，该公司的共识评级为 “持有”，平均目标价为 96.07 美元。</p>
</div><p><strong>Get Our Latest Report on MDT</strong></p>
<div class="lb-trans"><p><strong>获取我们关于 MDT 的最新报告</strong></p>
</div><h2>Insiders Place Their Bets</h2>
<div class="lb-trans"><h2>内部人士下注</h2>
</div><p>In other Medtronic news, EVP Brett A. Wall sold 9,850 shares of the firm's stock in a transaction on Wednesday, January 8th. The stock was sold at an average price of $80.41, for a total transaction of $792,038.50. Following the completion of the sale, the executive vice president now owns 40,708 shares of the company's stock, valued at $3,273,330.28. This trade represents a 19.48 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities &amp; Exchange Commission, which is available through the SEC website. 0.20% of the stock is owned by insiders.</p>
<div class="lb-trans"><p>在其他美敦力新闻中，执行副总裁 Brett A. Wall 于 1 月 8 日星期三出售了 9,850 股该公司的股票。该股票以 80.41 美元的平均价格出售，总交易额为 792,038.50 美元。交易完成后，该执行副总裁现在持有 40,708 股公司的股票，价值 3,273,330.28 美元。这笔交易代表其持股比例减少了 19.48%。该交易已在向证券交易委员会的法律文件中披露，相关信息可通过 SEC 网站获取。0.20% 的股票由内部人士持有。</p>
</div><h2>About Medtronic</h2>
<div class="lb-trans"><h2>关于美敦力</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免费报告）</p>
</div><p>Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software.</p>
<div class="lb-trans"><p>美敦力公司开发、制造和销售基于设备的医疗疗法，面向全球的医疗系统、医生、临床医生和患者。其心血管产品组合提供可植入的心脏起搏器、心脏复律除颤器和心脏再同步治疗设备；心脏消融产品；可植入心脏监测系统；TYRX 产品；以及远程监控和以患者为中心的软件。</p>
</div><h2>Recommended Stories</h2>
<div class="lb-trans"><h2>推荐故事</h2>
</div><ul>
<li>Five stocks we like better than Medtronic</li>
<li>Should You Add These Warren Buffett Stocks to Your Portfolio?</li>
<li>These 4 Tech ETFs Just Hit 50-Day Lows—Time to Buy?</li>
<li>Manufacturing Stocks Investing</li>
<li>3 Stocks to Buy While Others Stay on the Sidelines</li>
<li>Business Services Stocks Investing</li>
<li>MarketBeat Week in Review – 03/03 - 03/07</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票，胜过美敦力</li>
<li>你应该将这些沃伦·巴菲特的股票加入你的投资组合吗？</li>
<li>这四只科技 ETF 刚刚触及 50 日低点——是时候买入了吗？</li>
<li>制造业股票投资</li>
<li>在其他人观望时，值得购买的三只股票</li>
<li>商业服务股票投资</li>
<li>MarketBeat 周报 – 03/03 - 03/07</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1EVA" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=MDT"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Medtronic Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1000 美元在美敦力吗？</h2>
</div><p>Before you consider Medtronic, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑美敦力之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Medtronic wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而美敦力并不在名单上。</p>
</div><p>While Medtronic currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然美敦力目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Naviter Wealth LLC 增持了美敦力公司（NYSE:MDT）的股票头寸